Skip to main content
. Author manuscript; available in PMC: 2016 Sep 1.
Published in final edited form as: Cancer. 2015 Apr 30;121(17):2883–2891. doi: 10.1002/cncr.29438

Figure 3.

Figure 3

Risk of acquired hypogammaglobulinemia in patients with normal immunoglobulin levels at CLL diagnosis (n=1103). Solid line represents risk for all patients, and dashed line represents risk for patients who did not receive treatment for CLL.